Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.23090
Abstract: This cohort study evaluates the response to a third and fourth SARS-CoV-2 BNT162b2 vaccine dose among individuals aged 60 years or older by evaluating antispike immunoglobulin G antibody titers before and after each dose. read more here.
Keywords: third fourth; fourth sars; cov bnt162b2; vaccine dose ... See more keywords
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people
Sign Up to like & getrecommendations! Published in 2022 at "JCI Insight"
DOI: 10.1172/jci.insight.161045
Abstract: The immune factors associated with impaired SARS-CoV-2 vaccine response in the elderly are mostly unknown. We studied old and young people vaccinated with SARS-CoV-2 BNT162b2 mRNA before and after the first and second dose. Aging… read more here.
Keywords: cell; cov bnt162b2; vaccine response; bnt162b2 mrna ... See more keywords
A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
Sign Up to like & getrecommendations! Published in 2022 at "Upsala Journal of Medical Sciences"
DOI: 10.48101/ujms.v127.8959
Abstract: Background The hemodialysis (HD) population has been a vulnerable group during the coronavirus disease 2019 (COVID-19) pandemic. Advanced chronic kidney disease with uremia is associated with weaker immune response to infections and an attenuated response… read more here.
Keywords: response; cov bnt162b2; immune response; vaccine ... See more keywords